Prometheus Biosciences Inc (RXDX) PT Raised to $55 at Stifel
Tweet
Share
E-mailGet Alerts RXDX Hot Sheet
Price: $199.92 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Stifel analyst Annabel Samimy raised the price target on Prometheus Biosciences Inc (NASDAQ: RXDX) to $55.00 (from $50.00) while maintaining a Buy rating.
You May Also Be Interested In
- CIBC Upgrades PRO REIT (PRV-U:CN) to Outperformer
- Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
- Pou Sheng International (Holdings) Limited (3813:HK) (PSHGF) PT Raised to HK$0.54 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
